SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-22-073533
Filing Date
2022-03-11
Accepted
2022-03-11 17:05:01
Documents
3
Group Members
LEE S. AINSLIE IIIMAVERICK CAPITAL MANAGEMENT, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d264432dsc13ga.htm SC 13G/A 69556
2 EXHIBIT A d264432dex99a.htm EX-99.A 5221
3 EXHIBIT B d264432dex99b.htm EX-99.B 2954
  Complete submission text file 0001193125-22-073533.txt   79319
Mailing Address 1900 N. PEARL STREET, 20TH FLOOR DALLAS TX 75201
Business Address 1900 N. PEARL STREET, 20TH FLOOR DALLAS TX 75201 214.880.4050
MAVERICK CAPITAL LTD (Filed by) CIK: 0000934639 (see all company filings)

IRS No.: 000000000 | State of Incorp.: TX
Type: SC 13G/A

Mailing Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Subject) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88393 | Film No.: 22733964
SIC: 2836 Biological Products, (No Diagnostic Substances)